Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc− cystine transporter: a new action for an old drug

Goodman and Gilman's The Pharmacological Basis of Therapeutics

Hastings, R. C. (1996) · JAMA · doi:10.1001/jama.1996.03540120077042 · Cited by 2,375

Determination of subcutaneous tumor size in athymic (nude) mice

Tomayko, M. M., & Reynolds, C. P. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00300234 · Cited by 1,830

Cancer: Principles and Practice of Oncology

Gunn, W. G. (1994) · JAMA · doi:10.1001/jama.1994.03510350091047 · Cited by 1,803

Inhibition of NF-κB by Sodium Salicylate and Aspirin

Kopp, E. B., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,744

Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins

Sato, H., Tamba, M., Ishii, T., & Bannai, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11455 · Cited by 1,111

Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B

Wahl, C., Liptay, S., Adler, G., & Schmid, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci992 · Cited by 742

NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis

Wang, C.-Y., Guttridge, D. C., Mayo, M. W., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5923 · Cited by 594

Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion

Back, S. A., Gan, X., Li, Y., Rosenberg, P. A., & Volpe, J. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06241.1998 · Cited by 586

Exchange of cystine and glutamate across plasma membrane of human fibroblasts.

Bannai, S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35926-4 · Cited by 549

Analgesic-Antipyretic and Antiinflammatory Agents and Drugs Employed in the Treatment of Gout

Insel, P. (1996) · Medical Entomology and Zoology · Cited by 416

Posttranslational Modifications in Ferroptosis

Wei, X., Yi, X., Zhu, X., & Jiang, D. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8832043 · Cited by 165

Exploiting ferroptosis vulnerabilities in cancer

Nakamura, T., & Conrad, M. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01425-8 · Cited by 172

Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway

Chen, R.-S., Song, Y.-M., Zhou, Z.-Y., Tong, T., Li, Y., Fu, M., Guo, X.-L., Dong, L.-J., He, X., Qiao, H.-X., et al. (2008) · Oncogene · doi:10.1038/onc.2008.414 · Cited by 164

IFNγ-mediated repression of system xc− drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells

Kong, R., Wang, N., Han, W., Bao, W., & Lu, J. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma1220-815rrr · Cited by 164

The Relationship between Ferroptosis and Tumors: A Novel Landscape for Therapeutic Approach

Xia, X., Fan, X., Zhao, M., & Zhu, P. (2019) · Current Gene Therapy · doi:10.2174/1566523219666190628152137 · Cited by 161

Molecular and cellular mechanisms underlying brain metastasis of breast cancer

Hosonaga, M., Saya, H., & Arima, Y. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09881-y · Cited by 163

Mitochondria, cholesterol and cancer cell metabolism

Ribas, V., García‐Ruiz, C., & Fernández-Checa, J. C. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0106-5 · Cited by 166

GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma

Suzuki, S., Venkatesh, D., Kanda, H., Nakayama, A., Hosokawa, H., Lee, E., Miki, T., Stockwell, B. R., Yokote, K., Tanaka, T., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3914 · Cited by 168

Rapid Reaction, Slow Dissociation Aggregation, and Synergetic Multicolor Emission for Imaging the Restriction and Regulation of Biosynthesis of Cys and GSH

Yan, H., Huo, F., Yue, Y., Chao, J., & Yin, C. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c10840 · Cited by 157

MYCN -Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis

Floros, K. V., Cai, J., Jacob, S., Kurupi, R., Fairchild, C. K., Shende, M., Coon, C. M., Powell, K. M., Belvin, B. R., Hu, B., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1641 · Cited by 153

The synergistic effect between hydrogen peroxide and nitrite, two long-lived molecular species from cold atmospheric plasma, triggers tumor cells to induce their own cell death

Bauer, G. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101291 · Cited by 149

Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors

Chafe, S. C., Vizeacoumar, F. S., Venkateswaran, G., Nemirovsky, O., Awrey, S. J., Brown, W. S., McDonald, P. C., Carta, F., Metcalfe, A. L., Karasinska, J. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj0364 · Cited by 144

Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases

Cui, C., Yang, F., & Li, Q. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.901565 · Cited by 145

Induction and application of ferroptosis in cancer therapy

Nie, Q. H., Hu, Y., Yu, X. H., Li, X., & Fang, X. (2022) · Cancer Cell International · doi:10.1186/s12935-021-02366-0 · Cited by 146

Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib

Houessinon, A., François, C., Sauzay, C., Louandre, C., Mongélard, G., Godin, C., Bodeau, S., Takahashi, S., Saidak, Z., Gutierrez, L., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0526-2 · Cited by 137

USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy

Li, H., Sun, Y., Yao, Y., Ke, S., Zhang, N., Xiong, W., Shi, J., He, C., Xiao, X., Yu, H., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315541121 · Cited by 152

The x c − cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine

Guan, J., Lo, M., Dockery, P., Mahon, S., Karp, C. M., Buckley, A. R., Lam, S., Gout, P. W., & Wang, Y.-Z. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0894-4 · Cited by 134

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition

Sharbeen, G., McCarroll, J. A., Akerman, A., Kopecky, C., Youkhana, J., Kokkinos, J., Holst, J., Boyer, C. A., Erkan, M., Goldstein, D., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2496 · Cited by 135

Ferroptosis of immune cells in the tumor microenvironment

Kim, R., Taylor, D. K., Vonderheide, R. H., & Gabrilovich, D. I. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.06.005 · Cited by 143

Flavonoid-induced glutathione depletion: Potential implications for cancer treatment

Kachadourian, R., & Day, B. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.03.002 · Cited by 133

Decoding ferroptosis for cancer therapy

Wahida, A., & Conrad, M. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00864-1 · Cited by 168

Myeloid-Derived Suppressor Cells and anti-tumor T cells: a complex relationship

Monu, N. R., & Frey, A. B. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.673191 · Cited by 134

Quantitative modelling of amino acid transport and homeostasis in mammalian cells

Gauthier-Coles, G., Vennitti, J., Zhang, Z., Comb, W. C., Xing, S., Javed, K., Bröer, A., & Bröer, S. (2021) · Nature Communications · doi:10.1038/s41467-021-25563-x · Cited by 129

Multifaceted Roles of Glutathione and Glutathione-Based Systems in Carcinogenesis and Anticancer Drug Resistance

Hatem, E., Banna, N. E., & Huang, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7134 · Cited by 127

Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis

Xie, Y., Wang, B., Zhao, Y., Tao, Z., Wang, Y., Chen, G., & Hu, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01297-1 · Cited by 134

Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer

Lanzardo, S., Conti, L., Rooke, R., Ruiu, R., Accart, N., Bolli, E., Arigoni, M., Macagno, M., Barrera, G., Pizzimenti, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1208 · Cited by 130

Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization

Liu, N., Zhang, J., Yin, M., Liu, H., Zhang, X., Li, J., Yan, B., Guo, Y., Zhou, J., Tao, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.013 · Cited by 130

Solute Carrier Transporters as Targets for Drug Delivery and Pharmacological Intervention for Chemotherapy

Nakanishi, T., & Tamai, I. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22576 · Cited by 123

Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma

Guo, W., Zhao, Y., Zhang, Z., Tan, N., Zhao, F., Ge, C., Liang, L., Jia, D., Chen, T., Yao, M., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.024 · Cited by 122

Specific PET imaging of xC- transporter activity using a 18F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism

Koglin, N., Mueller, A., Berndt, M., Schmitt-Willich, H., Toschi, L., Stephens, A. W., Gekeler, V., Friebe, M., & Dinkelborg, L. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0687 · Cited by 120

Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer

Lo, M., Ling, V., Low, C., Wang, Y. Z., & Gout, P. W. (2010) · Current Oncology · doi:10.3747/co.v17i3.485 · Cited by 120

The Role of Iron, Its Metabolism and Ferroptosis in Traumatic Brain Injury

Tang, S., Gao, P., Chen, H., Zhou, X., Ou, Y., & He, Y. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.590789 · Cited by 120

Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials

Feng, Q., Yu, X., Qiao, Y., Pan, S., Wang, R., Zheng, B., Wang, H., Ren, K., Liu, H., & Yang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.858676 · Cited by 118

Ferroptosis: An emerging therapeutic opportunity for cancer

Wang, L., Chen, X., & Yan, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.09.005 · Cited by 120

Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy

Zheng, X., Jin, X., Ye, F., Liu, X., Yu, B., Li, Z., Zhao, T., Chen, W., Liu, X., Di, C., et al. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00427-w · Cited by 125

Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?

Macías‐Rodríguez, R. U., Inzaugarat, M. E., Ruiz‐Margáin, A., Nelson, L. J., Trautwein, C., & Cubero, F. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051651 · Cited by 116

Can NF-κB be a target for novel and efficient anti-cancer agents?

Olivier, S., Robe, P. A. J. T., & Bours, V. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.023 · Cited by 115

The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors

Zhu, J., Xiong, Y., Zhang, Y., Wen, J., Cai, N., Cheng, K., Liang, H., & Zhang, W. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8810785 · Cited by 116

Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression

Sui, S., Xu, S., & Pang, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107992 · Cited by 117

Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling

Koeberle, S. C., Kipp, A. P., Stuppner, H., & Koeberle, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21933 · Cited by 117

The Central Role of Amino Acids in Cancer Redox Homeostasis: Vulnerability Points of the Cancer Redox Code

Vučetić, M., Cormerais, Y., Parks, S. K., & Pouysségur, J. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00319 · Cited by 121

Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma

Zhang, H., Hughes, C. S., Li, W., He, J., Surdez, D., El-Naggar, A. M., Cheng, H., Prudova, A., Delaidelli, A., Negri, G. L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1690 · Cited by 111

Sulfasalazine‐induced cystine starvation: Potential use for prostate cancer therapy

Doxsee, D. W., Gout, P. W., Kurita, T., Lo, M., Buckley, A. R., Wang, Y., Xue, H., Karp, C. M., Cutz, J., Cunha, G. R., et al. (2006) · The Prostate · doi:10.1002/pros.20508 · Cited by 111

Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosis

Florean, C., Song, S., Dicato, M. A., & Diederich, M. F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.008 · Cited by 110

Ferrostatin-1 protects HT-22 cells from oxidative toxicity

Li, Q., Chu, J., Liu, C.-X., & Song, R. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266060 · Cited by 108

Amino Acid Transporters as Targets for Cancer Therapy: Why, Where, When, and How

Bröer, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176156 · Cited by 116

Using the Oxytosis/Ferroptosis Pathway to Understand and Treat Age-Associated Neurodegenerative Diseases

Maher, P. A., Currais, A. J. M., & Schubert, D. A. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.10.010 · Cited by 110

Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT

Lien, E. C., Ghisolfi, L., Geck, R. C., Asara, J. M., & Toker, A. (2017) · Science Signaling · doi:10.1126/scisignal.aao6604 · Cited by 104

The Mechanism of Ferroptosis and Applications in Tumor Treatment

Lin, X., Ping, J., Wen, Y., & Wu, Y. R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01061 · Cited by 107

Ferroptosis‐Enhanced Immunotherapy with an Injectable Dextran‐Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma

Meng, J., Yang, X. F., Huang, J., Tuo, Z., Hu, Y., Liao, Z., Tian, Y., Deng, S., Deng, Y., Zhou, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202300517 · Cited by 106

The Hallmarks of Cancer from a Redox Perspective

Hornsveld, M., & Dansen, T. B. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6580 · Cited by 105

Ferroptosis in Acute Central Nervous System Injuries: The Future Direction?

Shen, L., Lin, D., Li, X., Wu, H., Lenahan, C., Pan, Y., Xu, W., Chen, Y., Shao, A., & Zhang, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00594 · Cited by 102

Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies

Zhang, H., Zhang, E., & Hu, H. (2021) · Biomedicines · doi:10.3390/biomedicines9111660 · Cited by 104

Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy

Li, Q., Chen, K., Zhang, T., Jiang, D., Chen, L., Jiang, J., Zhang, C., & Li, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175913 · Cited by 106

Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers

Li, B., Yang, L., Peng, X., Fan, Q., Wei, S., Yang, S., Li, X., Jin, H., Wu, B., Huang, M., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110710 · Cited by 104

Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging

Ko, M. J., Min, S., Hong, H., Yoo, W., Joo, J., Zhang, Y. S., Kang, H., & Kim, D. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.09.015 · Cited by 101

Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma

Pi, M., Kuang, H., Yue, C., Yang, Q., Wu, A., Li, Y., Assaraf, Y. G., Yang, D., & Wu, S. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100822 · Cited by 98

Ferroptosis in life: To be or not to be

Xu, L., Liu, Y., Chen, X., Zhong, H., & Wang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114241 · Cited by 100

Exploring cysteine regulation in cancer cell survival with a highly specific “Lock and Key” fluorescent probe for cysteine

Liu, J., Liu, M., Zhang, H., Wei, X., Wang, J., Xian, M., & Guo, W. (2019) · Chemical Science · doi:10.1039/c9sc02618e · Cited by 95

Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity

Guo, Z., Liu, Y., Chen, D., Sun, Y., Li, D., Meng, Y., Zhou, Q., Zeng, F., Deng, G., & Chen, X. (2025) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2025-0004 · Cited by 111

Ferroptosis and Autoimmune Diseases

Lai, B., Wu, C., Wu, C., Luo, S., & Lai, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.916664 · Cited by 95

Comparative Evaluation of 18 F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents

Plöessl, K., Wang, L., Lieberman, B. P., Qü, W., & Kung, H. F. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.101279 · Cited by 95

Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis

Clayton, S. A., MacDonald, L., Kurowska‐Stolarska, M., & Clark, A. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673916 · Cited by 100

The immunobiology of myeloid-derived suppressor cells in cancer

Motallebnezhad, M., Jadidi‐Niaragh, F., Qamsari, E. S., Bagheri, S., Gharibi, T., & Yousefi, M. (2015) · Tumor Biology · doi:10.1007/s13277-015-4477-9 · Cited by 95

Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach

Chen, H., Wang, C., Liu, Z., He, X., Tang, W., He, L., Feng, Y., Liu, D., Yin, Y., & Li, T. (2022) · Antioxidants · doi:10.3390/antiox11081504 · Cited by 92

Regulated cell death in cancer: from pathogenesis to treatment

Gong, L., Huang, D., Shi, Y., Liang, Z., & Bu, H. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002239 · Cited by 95

SLC7A11 is an unconventional H+ transporter in lysosomes

Zhou, N., Chen, J., Hu, M., Wen, N., Cai, W., Li, P., Zhao, L., Meng, Y., Zhao, D., Yang, X., et al. (2025) · Cell · doi:10.1016/j.cell.2025.04.004 · Cited by 105

Ferroptosis, a Regulated Neuronal Cell Death Type After Intracerebral Hemorrhage

Bai, Q., Liu, J., & Wang, G. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.591874 · Cited by 95

Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia

Pardieu, B., Pasanisi, J., Ling, F., Bello, R. D., Penneroux, J., Su, A. H., Joudinaud, R., Chat, L., Wu, H.-C., Duchmann, M., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01573-6 · Cited by 97

Ferroptosis: Cancer Stem Cells Rely on Iron until “to Die for” It

Cosialls, E., Elhage, R., Santos, L. D., Gong, C., Mehrpour, M., & Hamaï, A. (2021) · Cells · doi:10.3390/cells10112981 · Cited by 94

Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy

Ebrahimi, N., Adelian, S., Shakerian, S., Afshinpour, M., Chaleshtori, S. R., Ravari, N. R., Rezaei‐Tazangi, F., Beiranvand, S., Hamblin, M. R., & Aref, A. R. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.01.006 · Cited by 91

Solute carriers (SLCs) in cancer

El-Gebali, S., Bentz, S., Hediger, M. A., & Anderle, P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.007 · Cited by 90

Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential

Procaccini, C., Garavelli, S., Carbone, F., Silvestre, D. D., Rocca, C. L., Greco, D., Colamatteo, A., Lepore, M. T., Russo, C., Rosa, G. D., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.014 · Cited by 89

High-fat diet impairs ferroptosis and promotes cancer invasiveness via downregulating tumor suppressor ACSL4 in lung adenocarcinoma

Zhang, Y., Li, S., Li, F., Lv, C., & Yang, Q. (2021) · Biology Direct · doi:10.1186/s13062-021-00294-7 · Cited by 85

Ferroptosis in viral infection: the unexplored possibility

Wang, M., Banda, J., Jin, N., Du, S., & Li, C. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00814-1 · Cited by 92

Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic Implications

Ju, H., Lu, Y., Chen, D.-L., Tian, T., Mo, H., Wei, X., Liao, J.-W., Wang, F., Zeng, Z.-L., Pelicano, H., et al. (2016) · Theranostics · doi:10.7150/thno.14848 · Cited by 87

Amino acid transporters as emerging therapeutic targets in cancer

Saito, Y., & Soga, T. (2021) · Cancer Science · doi:10.1111/cas.15006 · Cited by 86

Emerging Pathological Engagement of Ferroptosis in Gut Diseases

Gao, W., Zhang, T., & Wu, H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4246255 · Cited by 88

Ferroptosis in inflammatory arthritis: A promising future

Chang, S., Tang, M., Zhang, B., Xiang, D., & Li, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955069 · Cited by 91

Suppression of T cells by myeloid-derived suppressor cells in cancer

Chen, J., Ye, Y., Liu, P., Yu, W., Wei, F., Li, H., & Yu, J. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.12.001 · Cited by 87

Targeting extracellular nutrient dependencies of cancer cells

García‐Bermúdez, J., Williams, R. T., Guarecuco, R., & Birsoy, K. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.011 · Cited by 93

Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma

Nagane, M., Kanai, E., Shibata, Y., Shimizu, T., Yoshioka, C., Maruo, T., & Yamashita, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195151 · Cited by 86

Glutaminolysis‐related genes determine sensitivity to xCT‐targeted therapy in head and neck squamous cell carcinoma

Okazaki, S., Umene, K., Yamasaki, J., Suina, K., Otsuki, Y., Yoshikawa, M., Minami, Y., Masuko, T., Kawaguchi, S., Nakayama, H., et al. (2019) · Cancer Science · doi:10.1111/cas.14182 · Cited by 85

Targeting ferroptosis: Paving new roads for drug design and discovery

Gu, Y., Li, Y., Wang, J., Zhang, L., Zhang, J., & Wang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.115015 · Cited by 88

Cystathionine Is a Novel Substrate of Cystine/Glutamate Transporter

Kobayashi, S., Sato, M., Kasakoshi, T., Tsutsui, T., Sugimoto, M., Osaki, M., Okada, F., Igarashi, K., Hiratake, J., Homma, T., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.625053 · Cited by 87

The Role of SLC7A11 in Cancer: Friend or Foe?

Li, S., Lu, Z., Sun, R., Guo, S., Gao, F., Cao, B., & Aa, J. (2022) · Cancers · doi:10.3390/cancers14133059 · Cited by 87

Lipid Metabolism Regulates Oxidative Stress and Ferroptosis in RAS-Driven Cancers: A Perspective on Cancer Progression and Therapy

Bartolacci, C., Andreani, C., Elgammal, Y., & Scaglioni, P. P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.706650 · Cited by 86

The Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis in Inflammatory Bowel Disease, Colorectal Cancer, and Intestinal Injury

Zhou, P., Zhang, S., Wang, M., & Zhou, J. F. (2023) · Biomolecules · doi:10.3390/biom13050820 · Cited by 85

Ferroptosis: mechanisms and therapeutic targets

Zhou, Q., Meng, Y., Le, J., Sun, Y., Dian, Y., Yao, L., Xiong, Y., Zeng, F., Chen, X., & Deng, G. (2024) · MedComm · doi:10.1002/mco2.70010 · Cited by 89

Bioactivation of Napabucasin Triggers Reactive Oxygen Species–Mediated Cancer Cell Death

Froeling, F. E. M., Swamynathan, M. M., Deschênes, A., Chio, I. I. C., Brosnan, E., Yao, M. A., Alagesan, P., Lucito, M. S., Li, J., Chang, A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0302 · Cited by 82

Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor‐κB

Chung, W. J., & Sontheimer, H. W. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06129.x · Cited by 81

Iron metabolism and ferroptosis in human health and disease

Zhong, M., Wang, Y., Min, J., & Wang, F. (2025) · BMC Biology · doi:10.1186/s12915-025-02378-6 · Cited by 91

Therapeutic Insights on Ferroptosis in Parkinson's disease

Thapa, K., Khan, H., Kanojia, N., Singh, T. G., Kaur, A., & Kaur, G. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175133 · Cited by 76

Sulfasalazine-Induced Reduction of Glutathione Levels in Breast Cancer Cells: Enhancement of Growth-Inhibitory Activity of Doxorubicin

Narang, V. S., Pauletti, G. M., Gout, P. W., Buckley, D. J., & Buckley, A. R. (2007) · Chemotherapy · doi:10.1159/000100812 · Cited by 78

Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells

Okazaki, S., Shintani, S., Hirata, Y., Suina, K., Semba, T., Yamasaki, J., Umene, K., Ishikawa, M., Saya, H., & Nagano, O. (2018) · Oncotarget · doi:10.18632/oncotarget.26112 · Cited by 81

Issues in the Design and Interpretation of Chronic Toxicity and Carcinogenicity Studies in Rodents: Approaches to Dose Selection

Rhomberg, L. R., Baetcke, K. P., Blancato, J. N., Bus, J. S., Cohen, S. M., Conolly, R. B., Dixit, R., Doe, J. E., Ekelman, K., Fenner-Crisp, P., et al. (2007) · Critical Reviews in Toxicology · doi:10.1080/10408440701524949 · Cited by 77

Discovery and Mechanistic Elucidation of a Class of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma

Kyani, A., Tamura, S., Yang, S., Shergalis, A. G., Samanta, S., Kuang, Y., Ljungman, M. E., & Neamati, N. (2017) · ChemMedChem · doi:10.1002/cmdc.201700629 · Cited by 75

Immunogenic cell death in cancer immunotherapy

Choi, M., Shin, J., Lee, C.-E., Chung, J.-Y., Kim, M., Yan, X., Yang, W., & Cha, J. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0024 · Cited by 79

Redox‐based therapeutics in neurodegenerative disease

McBean, G. J., López, M. G., & Wallner, F. K. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13551 · Cited by 77

Cysteine transporter SLC3A1 promotes breast cancer tumorigenesis

Jiang, Y. Z., Cao, Y., Wang, Y., Li, W., Liu, X., Lv, Y., Li, X., & Mi, J. (2017) · Theranostics · doi:10.7150/thno.18005 · Cited by 78

In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine

Gout, P. W., Simms, C. R., & Robertson, M. C. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200301000-00004 · Cited by 39

Potential use for sulfasalazine in lung cancer therapy

Gout, P. W., Guan, J., Wang, Y., Xue, H., Doxsee, D., Sutcliffe, M., Cutz, J., LeRiche, J., Bebb, G. D., Lam, S. C., et al. (2004) · Cancer Research · Cited by 1

Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells

Gout, P., Kang, Y. J., Buckley, D., Bruchovsky, N., & Buckley, A. (1997) · Leukemia · doi:10.1038/sj.leu.2400739 · Cited by 53

210 Induction of apoptosis in chronic lymphocytic leukaemia by inhibition of NF-kB and novel sulfasalazine analogues

Packham, G., Habens, F., Mel, S. D., Srinivasan, N., Oakley, F., Mann, D. L., Potter, K. N., Stevenson, F. K., & Ganesan, A. (2004) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(04)80218-0

Abstract 1898: Regulation of cysteine supply for survival in hepatocellular carcinoma an breast cancer cell lines

Kim, D. H., & Lee, S. J. (2018) · Cancer Research · doi:10.1158/1538-7445.am2018-1898